U Tirelli Selected Research

Highly Active Antiretroviral Therapy (HAART)

06/2007	Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report.
08/2006	Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era.
04/2006	Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients.
12/2004	Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma.
07/2004	HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): some still unanswered questions for clinical management.
11/2001	[Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history]
07/2001	Impact of HAART on the clinical management of AIDS-related cancers.
04/2001	Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.
01/2001	Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
08/2000	Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
07/2000	Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.

Articles by Research Topic

Disease

9	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2005 - 01/2001
4	Lymphoma (Lymphomas) 01/2008 - 02/2001
3	Hodgkin Disease (Hodgkin's Disease) 12/2007 - 07/2000
3	Colorectal Neoplasms (Colorectal Cancer) 06/2007 - 04/2006
3	Neoplasms (Cancer) 10/2004 - 04/2001
2	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2008 - 04/2000
2	Chronic Hepatitis C 09/2001 - 03/2001
2	HIV Infections (HIV Infection) 09/2001 - 07/2000
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2001 - 04/2000
1	Infection 01/2008
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 10/2007
1	Neoplasm Metastasis (Metastasis) 08/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2006
1	Small Cell Carcinoma 09/2005
1	Voice Disorders (Voice Disturbances) 12/2004
1	Fatigue 10/2004
1	Prostatic Neoplasms (Prostate Cancer) 01/2004
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 08/2000
1	Primary Effusion Lymphoma 04/2000

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2004 - 01/2001
3	Prednisone (Sone)FDA LinkGeneric 03/2006 - 01/2001
3	vinorelbine (Navelbine)FDA LinkGeneric 03/2006 - 04/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2002 - 01/2001
2	oxaliplatin (Eloxatin)FDA Link 04/2006 - 12/2004
2	rituximab (Mabthera)FDA Link 08/2004 - 01/2002
2	Ribavirin (Virazole)FDA LinkGeneric 09/2001 - 03/2001
1	irinotecan (Camptosar)FDA LinkGeneric 04/2008
1	Ritonavir (Norvir)FDA Link 04/2008
1	lopinavir (Kaletra)FDA Link 04/2008
1	lenograstimIBA 12/2007
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2007
1	cetuximab (Erbitux)FDA Link 06/2007
1	Biological Markers (Surrogate Marker)IBA 08/2006
1	Interleukin-2 (IL2)IBA 08/2006
1	gefitinib (Iressa)FDA Link 09/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2004
1	CHVP protocol (CICS)IBA 03/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004
1	VAP-cyclo protocolIBA 09/2002
1	Interferon Alfa-2b (Interferon Alfa 2b)FDA Link 09/2001
1	Etoposide (VP 16)FDA LinkGeneric 07/2001
1	Syndecan-1 (Syndecan 1)IBA 02/2001
1	Vincristine (Oncovin)FDA LinkGeneric 01/2001
1	CyclinsIBA 04/2000

Therapy/Procedure

11	Highly Active Antiretroviral Therapy (HAART) 06/2007 - 07/2000
8	Drug Therapy (Chemotherapy) 06/2007 - 01/2001
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2008